5’ and N-protected -2, 2’-hydrocytine Glycoside tetrafluoroborate, under the action of weak alkali aqueous solution, opens the ring to generate 3’, 5’ and N-protected 2’-cytarabine, 3’, 5’ and N-protected 2-arabinose Cytidine is ...
Unlike intravascular large B-cell lymphoma, which is a well-recognized entity in the WHO classification, intravascular NK/T-cell lymphoma is not considered a specific entity and there is still a debate about whether it is closer to aggressive NK leukemia or to extranodal NK/T-cell lymphoma. ...
The R-CHOP immunochemotherapy protocol has been the first-line (1L) standard of care (SOC) for diffuse large B-cell lymphoma (DLBCL) patients for decades and is curative in approximately two-thirds of patients. Numerous randomized phase III trials, most